TLP Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,795
Closed -$194K 133
2018
Q3
$194K Buy
+1,795
New +$197K 0.31% 41
2018
Q2
Sell
-4,259
Closed -$427K 403
2018
Q1
$427K Buy
4,259
+4,200
+7,119% +$430K 0.29% 72
2017
Q4
$6K Buy
59
+1
+2% +$95 ﹤0.01% 424
2017
Q3
$5K Buy
+58
New +$6.16K ﹤0.01% 438
2017
Q2
Sell
-3,864
Closed -$379K 343
2017
Q1
$379K Buy
+3,864
New +$368K 0.26% 101
2016
Q4
Sell
-1,536
Closed -$130K 293
2016
Q3
$130K Buy
+1,536
New +$129K 0.14% 117
2016
Q2
Sell
-8,700
Closed -$622K 331
2016
Q1
$622K Buy
+8,700
New +$583K 0.38% 90

Other funds holding DGX

TLP Group's DGX Position: Q4 2018 in Review

TLP Group sold out of Quest Diagnostics (DGX) in Q4 2018, closing a stake of 1,795 shares — an estimated $194K sold.

TLP Group first reported a position in DGX in Q1 2016 and held it in 7 quarters. The position peaked at $622K in Q1 2016. 624 funds tracked by Wall St. Rank hold DGX as of Q4 2018.

  • TLP Group reported no remaining Quest Diagnostics position as of Q4 2018 after selling out during the quarter.
  • TLP Group sold 1,795 Quest Diagnostics shares in Q4 2018, an estimated $194K.
  • TLP Group first reported a position in Quest Diagnostics in Q1 2016 and held it in 7 quarters.
  • TLP Group's Quest Diagnostics position peaked at $622K in Q1 2016.
  • 624 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2018.

Based on TLP Group's 13F filing for Q4 2018, filed 14 Feb 2019.